30
CARDIOVASCULAR
hamburger

Objective Decisions.
Simplified Workflow.

Abbott’s newest generation of the PressureWire™ X Guidewire offers objective decisions with a simplified workflow.

The innovative PressureWire™ X Guidewire—the world’s only wireless physiology wire1—can measure pressure and temperature to calculate Abbott's Resting Full-Cycle Ratio (RFR), Fractional Flow Reserve (FFR), Index of Microvascular Resistance (IMR), and Coronary Flow Reserve (CFR). The guidewire’s fully integrated, secure, wireless measurements are integral to a cardiac cath lab’s clinical physiology routine. Abbott’s PressureWire™ X Guidewire and Coroventis CoroFlow Cardiovascular System, the only solution for the cath lab able to detect both epicardial disease and Coronary Microvascular Dysfunction (CMD).2-4

Pressurewire X Guidewire
Pressurewire X Guidewire
Pressurewire X Guidewire

Objective Decisions

  • Innovative sensor housing design offers <1 mmHg/30 min with reduction in drift due to microbubbles5
  • Objective decision-making with both RFR and FFR options
  • RFR has been studied in over 3,500 lesions and 2,000 patients6-10 to show diagnostic equivalence to iFR.
84% reduced drift with the latest PressureWire X Guidewire compared to its previous sensor housing design

Simplified Workflow

  • The PressureWire™ X Guidewire is the world’s only wireless physiology wire1
  • Wireless: from zero to go in 2 easy steps1
  • Ideal for the modern radial approach­
  • Compatible with the QUANTIEN™ Measurement System with an easy touchscreen workflow
  • Compatible with OPTIS™ Imaging Systems for imaging and physiology needs on one platform
Wireless PressureWire X Guidewire
2 Steps to Connect the Wireless
PressureWire™ X Guidewire1
  1. Zero. Zero the PressureWire™ X Guidewire by turning on the transmitter.
  2. Go. The transmitter’s function indicator shall display a stable green light when it is successfully zeroed.

References

  1. Volcano Corp. Verrata guidewire and PrimeWire Prestige Plus guidewire IFUs, Opsens Inc. OptoWire guidewire and OptoWire II guidewire IFUS, ACIST Medical Systems. Navvus Microcatheter IFU, Boston Scientific Corporation. Comet guidewire IFU, PressureWire™ X Guidewire IFU.
  2. Data on file at Abbott
  3. Ford TJ, Stanley B, Sidik N, et al. 1-year outcomes of angina management guided by invasive coronary function testing (CorMicA). JACC Intv. 2020; 13:33-45.
  4. Pijls NH, Fearon WF, Tonino PA, et al. Fractional Flow Reserve Versus Angiography for Guiding Percutaneous Coronary Intervention in Patients with Multivessel Coronary Artery Disease. 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) Study. JACC. 2010; 56(3): 177-184.
  5. Test(s) performed by and data on file at Abbott.
  6. Jeremias A, et al. Resting full-cycle ratio (RFR): a novel physiologic index compared to Fractional Flow Reserve (FFR) in assessing the hemodynamic severity of a coronary stenosis: ILUMIEN I + PREDICT. EuroPCR 2018.
  7. Svanerud J, et al. Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention. 2018;14:806-814.
  8. Ahn JM, et al. IRIS FFR: prognostic performance of five resting pressure-derived indexes of coronary physiology. TCT 2018.
  9. Kumar G. et al. Re-Validate Study. CRT 2019.
  10. Lee J-M, et al. Physiological and clinical assessment of resting physiological indexes. Circulation. 2019;139.

MAT-2003659 v1.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

True
accessibility
© 2016 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.